Clinical Trial Update: Long COVID-19 [11C]CPPC Study [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial update for the PET radiotracer [11C]CPPC in Long COVID, with the study listed as active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• [11C]CPPC (11C-CPPC)

Snippet

Sponsor: Johns Hopkins University | Conditions: COVID Long-Haul | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING